- 品牌:MedKoo
- 产地:美国
- 货号:206042
- cas:1421373-65-0
- 发布日期: 2022-07-20
- 更新日期: 2024-08-12
产地 | 美国 |
品牌 | MedKoo |
货号 | 206042 |
用途 | This product is for research use only, not for human or veterinary use. |
包装规格 | 1.0g; 2.0g; 5.0g; 10.0g; 20.0g; 50.0g; 100.0g; 500.0g; |
CAS编号 | 1421373-65-0 |
纯度 | >98%% |
是否进口 | 是 |
产品描述:奥瑞替尼(Osimertinib,又称AZD-9291和Mereletinib)是第三代EGFR抑制剂,在临床前研究中显示出了前景,并为对现有EGFR抑制剂产生耐药性的晚期肺癌患者提供了希望。AZD9291在临床前模型中具有高度活性,在动物模型中耐受性良好。它抑制激活和抗性EGFR突变,同时保留正常皮肤和肠道细胞中存在的正常形式的EGFR,从而减少当前可用药物的副作用。奥西美替尼于2015年11月获得FDA批准。
产品名称: Osimertinib free base
CAS#: 1421373-65-0 (free base)
分子式: C28H33N7O2
Exact Mass: 499.26957
分子量: 499.61
元素分析: C, 67.31; H, 6.66; N, 19.62; O, 6.40
Synonym: AZD9291; AZD 9291; AZD-9291; AZD-9291 freebase; Mereletinib; Osimertinib free base; trade name Tagrisso.
IUPAC/Chemical Name: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
InChi Key: DUYJMQONPNNFPI-UHFFFAOYSA-N
InChi Code: InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)
SMILES Code: C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
Appearance: Brown to yellow solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001